2018 - Member of the National Academy of Medicine (NAM)
2008 - Nobel Prize for their discovery of human immunodeficiency virus
Member of the European Molecular Biology Organization (EMBO)
Her scientific interests lie mostly in Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Antibody. Her research integrates issues of In vitro, Antigen and Phylogenetics in her study of Virology. Her Antigen research is multidisciplinary, incorporating elements of Deficiency syndrome, Leukemia, Persistent generalized lymphadenopathy and AIDS-related complex.
Her Virus research is multidisciplinary, relying on both Genome and Genetic variation. The various areas that Françoise Barré-Sinoussi examines in her Acquired immunodeficiency syndrome study include Viral disease, Clinical research, Viral hepatitis and Intensive care medicine. Her research in Antibody focuses on subjects like Immunopathology, which are connected to Radioimmunoassay and Radioimmunoprecipitation Assay.
Françoise Barré-Sinoussi mainly focuses on Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Antibody. Her Virology study often links to related topics such as Antigen. The concepts of her Virus study are interwoven with issues in Molecular biology and Peripheral blood mononuclear cell.
Her Molecular biology research incorporates elements of Cell culture and Reverse transcriptase. Françoise Barré-Sinoussi combines topics linked to In vitro with her work on Antibody. Her work carried out in the field of CD8 brings together such families of science as T cell and Cytotoxic T cell.
Her main research concerns Immunology, Immune system, Virology, Acquired immunodeficiency syndrome and Viral replication. Her Decidua research extends to Immunology, which is thematically connected. Her Immune system study incorporates themes from Cytotoxic T cell, Cytokine and Cell biology.
The Virology study combines topics in areas such as Inflammation, CXCL10 and Reverse transcriptase. Her work in the fields of Antiretroviral therapy overlaps with other areas such as Action. Her CD8 study combines topics from a wide range of disciplines, such as T cell and Virus.
Her primary areas of study are Immunology, Immune system, Virology, Acquired immunodeficiency syndrome and Cell biology. The various areas that she examines in her Immunology study include Cytotoxic T cell, Historical Article and Decidua. The study incorporates disciplines such as Receptor, Ligand, Human leukocyte antigen, Viral replication and Intracellular in addition to Immune system.
The Virology study combines topics in areas such as CXCL10 and CXCR3. Her work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Global population and Intensive care medicine. Her Innate immune system research includes elements of In vitro, Inflammation, Alpha interferon, CD16 and Antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
F. Barré-Sinoussi;J. C. Chermann;F. Rey;M. T. Nugeyre.
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.
D Klatzmann;F Barré-Sinoussi;M T Nugeyre;C Danquet.
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
François Simon;Philippe Mauclère;Pierre Roques;Ibtissam Loussert-Ajaka.
Nature Medicine (1998)
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
Asier Sáez-Cirión;Christine Lacabaratz;Olivier Lambotte;Pierre Versmisse.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Towards an HIV cure: a global scientific strategy
Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane.
Nature Reviews Immunology (2012)
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response
Béatrice Jacquelin;Véronique Mayau;Brice Targat;Anne Sophie Liovat.
Journal of Clinical Investigation (2009)
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
M Girard;M P Kieny;A Pinter;F Barre-Sinoussi.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.
Jean-Luc Darlix;Caroline Gabus;Marie-Thérèse Nugeyre;François Clavel.
Journal of Molecular Biology (1990)
Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines
L. Montagnier;J. Gruest;S. Chamaret;C. Dauguet.
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.
B. Spire;F. Barré-Sinoussi;D. Dormont;L. Montagnier.
The Lancet (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: